Mirabella Financial Services LLP Takes $14.29 Million Position in The Beauty Health Company (NASDAQ:SKIN)

Mirabella Financial Services LLP acquired a new stake in shares of The Beauty Health Company (NASDAQ:SKIN) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 8,988,571 shares of the company’s stock, valued at approximately $14,292,000. Beauty Health accounts for 1.3% of Mirabella Financial Services LLP’s portfolio, making the stock its 14th biggest position. Mirabella Financial Services LLP owned approximately 7.24% of Beauty Health as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in SKIN. SG Americas Securities LLC lifted its holdings in Beauty Health by 38.2% during the 4th quarter. SG Americas Securities LLC now owns 35,290 shares of the company’s stock valued at $56,000 after purchasing an additional 9,749 shares during the last quarter. Barclays PLC boosted its holdings in shares of Beauty Health by 11.1% in the 4th quarter. Barclays PLC now owns 117,920 shares of the company’s stock worth $187,000 after acquiring an additional 11,817 shares in the last quarter. Sanctuary Advisors LLC boosted its holdings in shares of Beauty Health by 49.2% in the 3rd quarter. Sanctuary Advisors LLC now owns 36,695 shares of the company’s stock worth $52,000 after acquiring an additional 12,103 shares in the last quarter. Raymond James Financial Inc. bought a new stake in Beauty Health during the 4th quarter worth approximately $25,000. Finally, Newman Dignan & Sheerar Inc. increased its stake in shares of Beauty Health by 39.1% in the fourth quarter. Newman Dignan & Sheerar Inc. now owns 71,144 shares of the company’s stock valued at $113,000 after buying an additional 20,000 shares in the last quarter. Institutional investors and hedge funds own 93.26% of the company’s stock.

Beauty Health Stock Down 1.6 %

Shares of NASDAQ SKIN opened at $0.85 on Friday. The company has a current ratio of 6.56, a quick ratio of 5.57 and a debt-to-equity ratio of 9.23. The firm has a market capitalization of $105.93 million, a PE ratio of -2.01 and a beta of 0.84. The firm’s 50-day moving average is $1.31 and its 200-day moving average is $1.50. The Beauty Health Company has a 1 year low of $0.83 and a 1 year high of $3.63.

Beauty Health (NASDAQ:SKIN) last released its earnings results on Wednesday, March 12th. The company reported ($0.08) EPS for the quarter, topping analysts’ consensus estimates of ($0.10) by $0.02. The firm had revenue of $83.50 million during the quarter, compared to analyst estimates of $78.02 million. Beauty Health had a negative net margin of 8.11% and a negative return on equity of 44.83%. During the same quarter in the previous year, the business earned ($0.07) EPS. Equities analysts expect that The Beauty Health Company will post -0.25 EPS for the current year.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group reduced their price objective on Beauty Health from $1.75 to $1.50 and set a “hold” rating on the stock in a report on Thursday, March 13th. One research analyst has rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $2.50.

Beauty Health Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.